Ureteral Stents Market Size & Share, By Product Type (Open End Stents, Double J-Stent), Material (Metallic Ureteral Stents, Polymer Ureteral Stents), Application (Kidney Stones, Kidney Transplantation), End-User (Hospitals, Clinics, Ambulatory Surgical Centers Or ASCs), Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Market Outlook:

Ureteral Stents Market size crossed USD 516.91 Million in 2023 and is likely to reach USD 858.59 Million by end of the year 2032, witnessing more than 5.8% CAGR between 2024 and 2032.

• Base Year Value (2023): USD 516.91 Million
• CAGR (2024-2032): 5.8%
• Forecast Year Value (2032): USD 858.59 Million
• Historical Data Period: 2019-2023
• Largest Region: North America
• Forecast Period: 2024-2032

Market Dynamics:

Growth Drivers & Opportunity:

1. Increasing prevalence of urological disorders: The rise in the prevalence of urological disorders such as kidney stones and urinary tract infections is expected to drive the demand for ureteral stents. According to the National Institute of Diabetes and Digestive and Kidney Diseases, kidney stones affect about 1 in 11 people in the United States, with a higher risk in men and non-Hispanic white people.

2. Technological advancements in stent design: Advancements in technology have led to the development of innovative ureteral stents with improved biocompatibility and reduced encrustation, providing better patient outcomes. These technological advancements are driving the adoption of ureteral stents in the market.

3. Growing aging population: The global aging population is a major demographic trend that is expected to drive the demand for ureteral stents. As people age, the risk of urological disorders increases, thereby leading to a higher demand for ureteral stents.

4. Increasing minimally invasive procedures: The shift towards minimally invasive procedures in urology, including the use of ureteral stents, is expected to drive market growth. Minimally invasive procedures offer several advantages such as shorter hospital stays, faster recovery, and reduced complications, driving the adoption of ureteral stents.

Report Scope

Report Coverage	Details
Segments Covered	Product Type, Material, Application, End-User
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	Boston Scientific, Coloplast., Allium Medical Solutions., Becton, Dickinson and Company, Cook Group Incorporated.

Industry Restraints:

1. Complications associated with stent insertion: The insertion of ureteral stents can lead to complications such as stent migration, urinary tract infection, and discomfort. These complications can hinder the adoption of ureteral stents and impact market growth.

2. Stringent regulatory requirements: The ureteral stents market is subject to stringent regulatory requirements, with stents needing to meet safety and efficacy standards before they can be approved for use. Meeting these requirements can be time-consuming and costly, posing a challenge for market players.

3. Limited reimbursement for stent procedures: Reimbursement policies for ureteral stent procedures vary across different regions, with limited coverage in some cases. This limited reimbursement can restrict the adoption of ureteral stents and impact market growth, especially in emerging economies.

Regional Forecast:

North America (U.S., Canada):

The North American market for ureteral stents is expected to witness steady growth due to the high prevalence of urological disorders and the availability of advanced healthcare infrastructure in countries like the United States and Canada. The increasing adoption of minimally invasive procedures and the presence of key players in the region are also contributing to market growth.

Asia Pacific (China, Japan, South Korea):

The Asia Pacific market for ureteral stents is anticipated to experience significant growth owing to the rising prevalence of kidney and urinary tract diseases in countries such as China, Japan, and South Korea. Additionally, the increasing healthcare expenditure, growing awareness about urological disorders, and technological advancements in healthcare facilities are driving the demand for ureteral stents in the region.

Europe (United Kingdom, Germany, France):

In Europe, the market for ureteral stents is expected to witness substantial growth due to the high incidence of urinary stone diseases and the presence of a well-established healthcare system in countries like the United Kingdom, Germany, and France. The increasing geriatric population and the rising demand for minimally invasive urological procedures are also contributing to the market expansion in the region.

Segmentation Analysis:

In terms of segmentation, the global ureteral stents market is analyzed on the basis of Product Type, Material, Application, End-User.

Ureteral Stents Market

Product Type

The product type segment of the ureteral stents market refers to the different types of stents available for ureteral management. This includes traditional stents, drug-eluting stents, and metallic stents. Traditional stents are the most commonly used and come in various sizes and lengths to accommodate different patient requirements. Drug-eluting stents are designed to slowly release medication to prevent complications such as urinary tract infections. Metallic stents are used in cases where a more permanent solution is required, such as in cases of malignant obstruction.

Material

The material segment of the ureteral stents market focuses on the different materials used to manufacture stents. This includes silicone, polyurethane, and metal. Silicone stents are flexible and are often preferred for patients who need long-term stent placement. Polyurethane stents are known for their durability and compatibility with the urinary tract. Metal stents, typically made of stainless steel or nitinol, are used in cases where greater mechanical strength is required.

Application

The application segment of the ureteral stents market refers to the different medical conditions and procedures for which stents are used. This includes urolithiasis, hydronephrosis, and strictures. Urolithiasis, or kidney stones, often requires the use of stents to help with the passing of stones and to relieve urinary obstruction. Hydronephrosis, a condition characterized by the swelling of the kidneys due to obstruction, may also require stent placement to restore proper urine flow. Strictures, or narrowing of the ureter, can be managed with the use of stents to maintain patency.

End-User

The end-user segment of the ureteral stents market refers to the different healthcare facilities and professionals involved in the use of stents. This includes hospitals, ambulatory surgical centers, and urology clinics. Hospitals are the primary end-users of ureteral stents, with a high volume of stent placements being performed in various departments such as urology, nephrology, and interventional radiology. Ambulatory surgical centers are also significant end-users, especially for outpatient procedures. Urology clinics may also utilize ureteral stents for various diagnostic and therapeutic purposes.

Competitive Landscape:

The competitive landscape in the Ureteral Stents Market is characterized by intense competition among key players striving to gain a competitive edge through product innovation, strategic partnerships, and geographical expansion. The market is witnessing a growing demand for advanced ureteral stents that offer improved patient outcomes and reduced complications. Key players are focusing on developing stents with enhanced biocompatibility and durability to meet the evolving needs of healthcare professionals and patients. Furthermore, the market is also witnessing a rise in the adoption of minimally invasive procedures, which is driving the demand for ureteral stents. Companies are investing in research and development activities to introduce technologically advanced stents, which is further intensifying the competition in the market.

Top Market Players:

1. Boston Scientific Corporation

2. Cook Medical Inc.

3. C. R. Bard, Inc. (Becton, Dickinson and Company)

4. B. Braun Melsungen AG

5. Coloplast A/S

6. Teleflex Incorporated

7. Merit Medical Systems, Inc.

8. Olympus Corporation

9. Allium Medical Solutions Ltd.

10. Medi-Globe Corporation